In this issue:
Evinacumab in patients with refractory hypercholesterolaemia
Evolocumab + statin therapy in patients with metabolic syndrome
Influence of Lp(a) levels on the benefits of PCSK9 inhibition in patients with nominally controlled LDL cholesterol
Lipid-lowering effects of bempedoic acid when added to a PCSK9 inhibitor
Single-pill combination of statin + ezetimibe improves adherence
A possible explanation for the contrasting results of REDUCE-IT and STRENGTH trials
Effects of statins on progression of coronary atherosclerotic plaque composition
Statin treatment and outcomes after ESUS
Lipid-lowering treatment patterns in the US over a 2-year period
Statin adherence and lipid targets in MI survivors
Long-term follow-up of HOPE-3 study participants
Influence of Lp(a) on outcomes in patients with acute ischaemic stroke
PCSK9 inhibitors in patients with elevated creatine phosphokinase levels
Generalisability of the REDUCE-IT trial findings
Please login below to download this issue (PDF)